Evidence map›Paper›PMID 36671311›Full record

ArticleAntibiotics (Basel, Switzerland)2023

In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic

Harpreet Kaur, Naveen Chaudhary, Vinay Modgil, Manmohit Kalia, Vishal Kant, Balvinder Mohan, Alka Bhatia, Neelam Taneja

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. n-Butanol Extract ofCurrent issues in molecular biology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Harpreet KaurDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Naveen ChaudharyDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Vinay ModgilDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.ORCID 0000-0001-7214-241X
Manmohit KaliaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Vishal KantDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Balvinder MohanDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Alka BhatiaDepartment of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Neelam TanejaDepartment of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.ORCID 0000-0003-1198-6138
Post Graduate Institute of Medical Education and Research · INBinghamton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, urinary tract infections (UTIs) are one of the most frequent bacterial infections. Uropathogenic

Indexed as

heraclenolHisCin vitroin vivomultidrug resistanceurinary tract infections

Identifiers

PMID36671311
PMCPMC9854483
OpenAlexW4313826312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.